GYNAECOLOGICAL CYTOLOGY
|
|
- Jessica Bishop
- 6 years ago
- Views:
Transcription
1 The laboratory runs a tour of the department for Practice Nurses on request, as part of their training, explaining the procedures and requirements for Gynae LBC. RECOMMENDED PROTOCOL FOR SMEAR TAKERS Only take the sample if the woman is due for a sample Only Cytyc thin prep kits must be used. All smear takers must be suitably trained to take Cytyc thin prep samples and have their own unique smear taker identity number. Only use LBC vials provided by the laboratory and ensure they are within the expiry date. Expired vials cannot be processed. Do not use any other containers. One sample per patient is adequate. The vial has an area provided for recording patient information. For hand written entries, use permanent markers or inks that will not rub off or blur (not ball point pens). Complete the label on the LBC vial immediately before taking the sample. Never label vials in advance. Include First name, Surname, DOB and NHS number. Check directly with the woman for accuracy. The following samples will be rejected and the laboratory will notify the sender. Specimen received unlabelled. Absence of 2 or more of key demographic information. (Patient s full name and NHS number or date of birth or Hospital number). Major mismatch of key demographic information. Out of programme samples: Samples from women under 24.5 years unless woman is on routine recall after previously tested at 20 years in Wales, Scotland or Northern Ireland, being followed up for previous abnormal cytology, being followed up after having and incidental biopsy showing CIN but have had no prior cytology, taken by a colposcopist/gynaecologist where they have clearly documented on the request form the rationale for taking the sample. Samples from women over 65 unless woman unscreened, missed last invitation at 60 or is in follow up for previous abnormal Samples taken more than 6 months ahead of schedule following a routine recall Samples taken at an inapropriate period after a previous HPV negative test and returned to routine recall Samples requested following an unreliable HPV test repeated in less than 3 months as part of a test of cure QPulse record: Pathology 2436 Revision: 7 Page 1 of 5
2 Unreliable HPV test repeated in less than 6 months as part of a triage Samples taken inappropriately at colposcopy contrary to the NHSCSP HPV testing implementation guidelines Samples taken less than 3 months ahead of schedule following a previous inadequate test Vault samples from women with total hysterectomy for non-cervical malignancy or benign conditions. 1. No fluid in vial received 2. Samples received without a form, sender contacted and no form received or found within 2 days. 3. Form received without a sample, sender contacted and no sample received or found within 2 days. 4. No form received with sample Unable to trace the sender 5. No sample received with form Unable to trace the sender 6. Sample received in the wrong type of container e.g formalin pot 7. Specimen received in an out of date vial For further information regarding labelling of specimens. refer to document Pathology: General guidance on completing request forms, request forms in use & labelling specimens If your clinic prepares patient information via adhesive label, place the label over the PreservCyt solution vial label. However, take care not to overlap multiple labels and do not obscure the frosted areas on the vial. Apply labels smoothly and evenly; all edges should be flat and contacting the surface of the vial. Where possible, limit the number of labels placed onto the vial. Do not place labels on top of the vial cap or on the bottom of the vial or over the expiry date of the vial. Do not use any adhesive tapes on vials. Do not place the brush head in the vial. QPulse record: Pathology 2436 Revision: 7 Page 2 of 5
3 Please ensure that vial lid is not cross-threaded, then is securely tightened, some vials will be provided with a black line on the lid and vial, please ensure the lid is tightened so that the black lines correspond. Remove any remaining cellophane from the vial. Place in a specimen transport bag with the vial in the sealed part and the corresponding form in the plastic sleeve of the bag. What to do if the vial contents are spilt It is important for the laboratory to know if the sample was added before or after the contents were spilt. If the vial is knocked over after the sample has already been added to the fluid in the vial: Look to see if any fluid still remains in the vial. If about 1/3 of the fluid still remains, continue to send the sample to the laboratory for processing and make a note on the request form to inform the laboratory that the sample was added before the spillage occurred. Do not top up the vial with fluid from a new vial as the laboratory will make the necessary adjustments. If less than 1/3 of the fluid remains, continue to send the sample to the laboratory for processing and make a note on the request form to inform the laboratory that the sample was added before the spillage occurred. Do not top up the vial with fluid from a new vial. The laboratory will issue an inadequate report and the sample should be repeated after an interval of 3 months. Overfull vials will be queried with the sender before any processing can be done If the vial is knocked over before the sample has been added to the fluid in the vial: Use a new vial for the sample. Remember to re-label the new vial correctly. Discard the unused vial. Request form Please ensure the information on the accompanying request form matches that on the LBC vial, including the correct collection date. This will avoid delays in processing the specimen. Always include the patient s current home address. Where the result is not to be sent to the home address state No letter to home address clearly on the form, then give an alternative address wherever possible stating clearly on the form where the result is to be sent. QPulse record: Pathology 2436 Revision: 7 Page 3 of 5
4 The sample will not be processed if the sample test date is missing. Clarification of missing or unclear information will be required from the sender in writing before sample processing is undertaken. Document clearly when the cervix is not fully visualised. Smear takers should write their unique identification code on all the request forms. The request form must be signed and dated (where applicable) by the sample taker. The laboratory will only accept samples from suitably trained samples takers trained in the Thinprep method who have been issued with a PIN. The sample taker PIN must be written on the request form (close to the sample taker signature). Please note that samples taken by untrained senders and/or by sample takers not on the laboratory PIN log will be destroyed. PIN are managed and issued by the laboratory and all enquiries/requests for PIN should be addressed through the Cytology Administrator on the above contact telephone number If the samples are taken at the colposcopy clinic, always write the colposcopic opinion of the cervix. If the woman has any previous history of treatment to her cervix record the histology results, date and type of treatment on the request form.( i.e LLETZ, cone biopsy, cold coagulation or cervical biopsy). This information is particularly important if treatment has been carried out elsewhere. Patients HIV status (if HIV positive) must be provided on the request form to aid accurate management. A Patient-specific form is available to download from the Open Exeter website. This can include some previous Cervical Cytology history from elsewhere and is preferred form of use. GP practices with multiple doctors - please ensure that you write the GP s name on the form, and on all copies of a multipart form not just the stamp of the surgery. For further information regarding labelling of specimens, refer to document Pathology: General guidance on completing request forms, request forms in use & labelling specimens QPulse record: Pathology 2436 Revision: 7 Page 4 of 5
5 Endocervical Brush Samples. Brush samples should be taken at the same time as a LBC sample. Brush samples should not be used alone for screening purposes. Endocervical Brush samples are requested if: An endocervical lesion is suspected. In post cone follow-up. Tight Cx OS. Factors that can affect the result: The use of lubricant during LBC sample taking is not recommended as this can lead to inadequate processing. A mid - cycle sample is the sample of choice as menstrual samples may lead to inadequate processing. The recent use of talcum powder, Canestan (or similar) pessaries may lead to contamination of the sample. The presence of a brush head in the sample (if no dyskaryosis is seen) will lead to an inadequate report being issued. The sample taker will be informed. When the cervix is not fully visualised and if no dyskaryosis is reported, an inadequate report will be issued. The presence of TZ (Transformation Zone) sampling is required in follow up samples from patients with a history of CGIN. When samples are reported as inadequate or if the laboratory reports an unprocessed sample, repeat cytology should not be performed less than three months after a previous test. Consumable stock ordering and storage All LBC consumables necessary for taking cervical cytology specimens are supplied by the Cytology laboratory at Queens hospital NHS trust. To request stock either telephone the laboratory on ext ( ext. 3684) or alternatively complete an order form supplied by the cytology laboratory and return by fax or with samples. LBC vials should be stored at 15 C 30 C and cervix brushes should be stored at room temperature or on open shelves. We do not recommend sample takers hold vast quantities of stock and it should be rotated to ensure it does not exceed the use by date. QPulse record: Pathology 2436 Revision: 7 Page 5 of 5
SE Coast Cervical Screening QARC Interim Guidance for laboratories on cervical sample acceptance
SE Coast Cervical ing QARC Interim Guidance for laboratories on cervical sample acceptance List of accepted reasons/categories for sample rejection and inadequate cytology reports in SE Coast Version 6,
More informationCELLULAR PATHOLOGY DEPARTMENT STANDARD OPERATING PROCEDURE INSTRUCTIONS FOR CERVICAL CYTOLOGY SAMPLE TAKERS
Implementation date: October 2006 Page 1 of 7 CELLULAR PATHOLOGY DEPARTMENT STANDARD OPERATING PROCEDURE INSTRUCTIONS FOR CERVICAL CYTOLOGY SAMPLE TAKERS Purpose: This procedure has been written to provide
More informationNHS Cervical Screening Programme. Guidance for acceptance of cervical screening samples in laboratories and pathways, roles and responsibilities
NHS Cervical Screening Programme Guidance for acceptance of cervical screening samples in laboratories and pathways, roles and responsibilities Public Health England leads the NHS Screening Programmes
More informationWIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS
Author J. Evans BMS 3 Authoriser A. Bamber Page 1 of 16 WIRRAL UNIVERSITY TEACHING HOSPITAL CYTOLOGY NHS CERVICAL SCREENING PROGRAMME INFORMATION PACK FOR SAMPLE TAKERS Author J. Evans BMS 3 Authoriser
More informationScottish Cervical Screening Programme. Colposcopy and Programme Management
Scottish Cervical Screening Programme Colposcopy and Programme Management Addendum to NHSCSP Publication No 20 Second Edition Exceptions Applicable in NHS Scotland April 2013 (Final Version 2.8 to incorporate
More informationCytology Update M Laing QEUH
Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME
More informationInformation on: HPV testing. jostrust.org.uk
Information on: HPV testing jostrust.org.uk HPV testing This booklet covers: What is HPV? How do you get HPV? HPV testing Results of HPV testing Jo s Cervical Cancer Trust 2 What is HPV testing? Human
More informationINFORMATION PACK FOR CERVICAL SAMPLE TAKERS DECEMBER 2018
Manchester Cytology Centre NHS Cervical Screening Programme INFORMATION PACK FOR CERVICAL SAMPLE TAKERS DECEMBER 2018 The Manchester cervical screening laboratory is UKAS accredited to ISO15189:2012 Page
More informationNorthern Ireland Cervical Screening Programme
Northern Ireland Cervical Screening Programme ANNUAL REPORT & STATISTICAL BULLETIN 2010-2011 1 Report produced by : Quality Assurance Reference Centre, PHA Date of Publication: September 2012 2 Contents
More informationCervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital
Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before
More informationManchester Cytology Centre APRIL 2012
Directorate of Laboratory Medicine Manchester Cytology Centre NHS Cervical Screening Programme INFORMATION PACK FOR SAMPLE TAKERS APRIL 2012 April 2012 [CYT GEN 029 Version 004] 1 SUMMARY OF CHANGES Page
More informationGUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) Approved by Guidelines Assessment Panel
NORFOLK & WAVENEY CELLULAR PATHOLOGY SERVICE GUIDELINES FOR CERVICAL CYTOLOGY SPECIMENS CA1066 (V8) DEPT. SOP NO.:C.SC.I.806b EDITION: 8 AUTHORISED BY: See table below AUTHOR: VIKI FREW DATE OF ISSUE:
More informationInformation on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
More informationInformation on: Cervical. screening. (smear test) jostrust.org.uk
Information on: Cervical screening (smear test) jostrust.org.uk Cervical screening This booklet covers: What is cervical screening? Who is eligible for screening? What happens when I have a screening sample
More informationPOLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS
POLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS Reference Number Version: Status Author: Alison Cropper CL-CP/2009/010 V3 Final Job Title: Hospital Based Programme
More informationPrimary High Risk HPV Testing with Cytology Triage
Primary High Risk HPV Testing with Cytology Triage NHS Cervical Screening Programme Public Health England leads the NHS Screening Programmes Human papillomavirus (HPV) High risk (HR) HPV is associated
More informationGloucestershire Cervical Screening Programme Guidelines
Gloucestershire Cervical Screening Programme Guidelines February 2015 1 Cervical Screening Programme Guidelines Page 1 Version: 6.0 Issued: February 2014 Notes: Please note that this extensive document
More informationSTOP Cancer, before it starts*
About your cervical screening (smear test) Going for screening could save your life. STOP Cancer, before it starts* This leaflet is available in Easy Read, BSL, audio and large print. www.cervicalscreeningwales.wales.nhs.uk
More informationSpecimen Collection & Handling Instructions HUMAN PAPILLOMAVIRUS (HPV) COLLECTION IN SUREPATH
HUMAN PAPILLOMAVIRUS (HPV) COLLECTION IN SUREPATH NOTE: HPV TESTING IS NOT FUNDED BY MOHLTC Patient payment of $90.00 is required HPV testing can be used to refine the management of women over the age
More informationCERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02
CERVICAL SCREENING WALES INFORMATION TEAM STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2001/02 For more information about this report contact: Helen Beer, Information Analyst / Manager, Screening
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationAdjunctive colposcopy technologies for examination of the uterine cervix DySIS, LuViva Advanced Cervical Scan and Niris Imaging System
Appendix 9 Further LuViva analysis Following several requests for clarification and extra information Guided Therapeutics provided two tables on the accuracy of LuViva and colposcopy (personal correspondence
More informationAbout your cervical screening (smear test) Going for screening could save your life.
About your cervical screening (smear test) Going for screening could save your life. STOP Cancer, before it starts This leaflet is available in Easy Read, BSL, audio and large print. www.cervicalscreeningwales.wales.nhs.uk
More informationCuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015
Programme Report 2014/2015 Contents Summary points 2 Introduction to the statistics 2014/2015 3 Part 1 Cervical screening activity 3 Programme coverage 4 Laboratory turnaround time 7 Notification of results
More informationNorthern Ireland cervical screening programme. Information for primary care and smear takers
Northern Ireland cervical screening programme Information for primary care and smear takers From January 2011, the Northern Ireland cervical screening programme will no longer invite women aged under 25
More informationKC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales
KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales CERVICAL SCREENING WALES STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2012/2013 For more information
More informationEfficacy of cervical intrarepithelial neoplasia (CIN)
The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,
More informationCERVICAL SCREENING WALES
CERVICAL SCREENING WALES Cervical Screening Wales Audit of Cervical Cancer (CSWACC) National Report 1999-2009 For more information about this report contact: Dr Rose Fox Director Cervical Screening Wales
More informationZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust
ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection
More informationInformation about. Cervical screening. (smear test) jostrust.org.uk
Information about Cervical screening Cervical screening (smear test) jostrust.org.uk About this booklet This booklet is for anyone who has been invited for cervical screening (a smear test) or is interested
More informationProvidence Medford Medical Center Pathology Department
Providence Medford Medical Center Pathology Department Anatomic pathology services including histology, cytology and autopsies are offered through Providence Medford Medical Center Pathology Department.
More informationThe routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy
The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates
More informationAbnormal Smear (Cytology) Results What do they mean?
Abnormal Smear (Cytology) Results What do they mean? Obstetrics & Gynaecology Women & Children s Services This leaflet has been designed to give you important information about your condition / procedure,
More information07 August Dear Colleague,
07 August 2018 Dear Colleague, Further to our letter dated 9 May 2018, we are writing today to all healthcare professionals registered with CervicalCheck with updated advice and information regarding CervicalCheck.
More informationNHS cervical screening Helping you decide
NHS cervical screening Helping you decide What is cervical cancer? 2 What causes cervical cancer? 2 What is cervical screening? 3 Cervical screening results 6 What is a colposcopy? 8 Making a choice the
More informationTO TEST, OR NOT TO TEST? THAT IS THE QUESTION. Cervical screening guide for lesbian and bisexual women in Norfolk and Waveney.
TO TEST, OR NOT TO THAT IS THE QUESTION. Cervical screening guide for lesbian and bisexual women in Norfolk and Waveney. TEST? Every effort has been made to ensure that the information provided is accurate.
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationHistopathology Laboratory. Handbook. Version : 2.14 Page 1 of 12. Active Date : 6/7/17 Review due : 6/7/18
Histopathology Laboratory Handbook Version : 2.14 Page 1 of 12 Contents 1.0 SUMMARY OF REVISIONS... 1 2.0 INTRODUCTION... 2 3.0 HIGH RISK SPECIMENS... 2 4.0 GENERAL... 2 4.1 SPECIMEN RECEPTION... 2 4.2
More informationcle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22
BJMP 2008:1(2) 18-22 Review Articl cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil Abbreviations BSCCP British Society of Colposcopy and Cervical Pathology CIN Cervical intraepithelial
More informationCERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix
More informationNATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor 2017
a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a NATIONAL CERVICAL CANCER SCREENING PROGRAMME Monitor
More informationTo further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy
1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous
More informationYou have been asked to come for a Colposcopy examination because your cervical screening test (smear) has shown evidence of abnormal cells.
Colposcopy Examination One Stops Patient Information Sheet Why do I need a Colposcopy examination at the one stop clinic? You have been asked to come for a Colposcopy examination because your cervical
More informationManagement of Abnormal Cervical Cytology and Histology
Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline
More informationSpecimen Collection Techniques and Fixation Procedures
Specimen Collection Techniques and Fixation Procedures Conventional Gynecological Sources Vaginal, Cervical, Endocervical Smears For optimal gynecologic cytology, it is recommended that the cellular samples
More informationAn evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme Sherlaw-Johnson C, Philips Z
An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme Sherlaw-Johnson C, Philips Z Record Status This is a critical abstract of an economic
More informationThe new Cervical Screening Test for Australian women: Louise Farrell
The new Cervical Screening Test for Australian women: Louise Farrell Outline and explain the changes to the National Cervical Screening Program due to commence in Dec 2017 LEARNING OBJECTIVES FOR TODAY
More informationCERVICAL SCREENING. a pocket guide. Cancer Screening Programmes
CERVICAL SCREENING a pocket guide Cancer Screening Programmes CERVICAL SCREENING a pocket guide This booklet is a simple guide to cervical screening. We hope you find it useful whether you work for or
More informationNational Screening Programmes (Adult Population) Annual Report
National Screening Programmes (Adult Population) Annual Report 2011-12 1 This report details the range of national screening programmes for the adult population offered by NHS Shetland and reports the
More informationPreventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE
Preventing Cervical Cancer 2018 WHAT THIS WILL MEAN FOR PRIMARY CARE DR GARY FENTIMAN, CLINICAL LEADER COLPOSCOPY, N C S P TAKE-HOME LESSONS Vaccination is Primary Prevention for Cervical Cancer Women
More informationThe implications of HPV immunisation on cervical screening
The implications of HPV immunisation on cervical screening Dr Maggie Cruickshank Senior Lecturer in Gynaecology Scottish Cervical Cancer Prevention Programme (SCCPP) funded by CSO Cervical screening Detects
More informationNorthern Ireland Bowel Cancer Screening Programme. Pathways. Version 4 1 st October 2013
Northern Ireland Bowel Cancer Screening Programme Pathways These changes will be version controlled, led by the Quality Assurance Director for the Programme. Any updated versions will be circulated and
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationGloucestershire Hospitals NHSFT Pathology Policy for Specimen and Request form Labelling for Pathology Users
Gloucestershire Hospitals NHSFT Pathology Policy for Specimen and Request form Labelling for Pathology Users This policy sets out the principles for the adequate identification of Pathology specimens and
More informationHow invasive cervical cancer audit affects clinical practice
How invasive cervical cancer audit affects clinical practice Referring to NHSCSP and EU guidelines and audits in Southampton and London Amanda Herbert Guy s & St Thomas Foundation NHS Trust How invasive
More informationCervical Screening - The Facts Sgrinio Serfigol - Y Ffeithiau AWARDED FOR EXCELLENCE
Cervical Screening - The Facts Sgrinio Serfigol - Y Ffeithiau AWARDED FOR EXCELLENCE This leaflet tells you about cervical screening. Cervical Screening Wales (CSW) invites all eligible women who live
More informationPathology Specimen Handling Requirements
CONWAY REGIONAL HEALTH SYSTEM CLINICAL LABORATORY Pathology Specimen Handling Requirements POLICY: Tissue or body fluids, etc. removed or collected during any procedure for purposes of Pathologist examination
More informationTechnical Bulletin No. 98b
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 98b Chlamydia trachomatis and Neisseria gonorrhoeae Dual Target PCR Assay UPDATED Specimen Requirements October 13, 2016 Contact: Susan
More informationThe introduction of HPV testing to cervical screening in Scotland
The introduction of HPV testing to cervical screening in Scotland Frequently asked questions for professionals Key messages From early 2020, cervical cytology (looking at cells under a microscope) will
More informationNHSCSP AUDIT OF INVASIVE CERVICAL CANCER: NATIONAL REPORT
NHSCSP AUDIT OF INVASIVE CERVICAL CANCER: NATIONAL REPORT 2009-2012 NHSCSP audit of invasive cervical cancer: national report 2009-2012 i Lead Authors Professor Peter Sasieni Professor of Biostatistics
More informationEFCS Symposium. Is cervical cancer screening based on HPV testing with cytology triage as safe as perceived?
EFCS Symposium Is cervical cancer screening based on HPV testing with cytology triage as safe as perceived? Amanda Herbert Guy s & St Thomas NHS Foundation Trust Is cervical cancer screening based on HPV
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document
More informationInformation for trans people
NHS Screening Programmes Public Health England leads the NHS Screening Programmes About this leaflet This leaflet is for trans (transgender) and non-binary people in England. It tells you about the adult
More informationSCREENING MATTERS - Issue 26
SCREENING MATTERS - Issue 26 What s in this issue? [Front page] Call/recall Breast screening Practice visit [2] Text reminders Implementation of digital mammography Breast screening leaflets [3] Breast
More informationThe role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial
DOI: 10.1111/j.1471-0528.2010.02519.x www.bjog.org Epidemiology The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial
More informationZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust
ZedScan Case Study NHS Hospital, UK. ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust Increased detection
More informationThe Renewed National Cervical Screening Program:
The Renewed National Cervical Screening Program: Key information for Health Professionals Contents: Overview: National Cervical Screening Program... 2 Background: HPV and cervical cancer... 3 HPV testing
More informationBASE 24-HOUR URINE COLLECTION LITHOLINK CORE LAB
CHAPTER 34. BASE 24-HOUR URINE COLLECTION LITHOLINK CORE LAB 34.1 Background Participants who are enrolled in the CKD BASE Study will collect urine over a 24-hour period at B0, W12 and W28. A 50 ml tube
More informationPlus ça change. CWE Redman Colposcopy Symposium, ECC 2016
Plus ça change. CWE Redman Colposcopy Symposium, ECC 2016 UHNM What we know HPV primary screening coming More sensitive: more HSIL detected Increase in workload Longer consultations More anxiety HPV Primary
More informationWhat Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
More informationCervical Screening A guide for women in New Zealand
Cervical Screening 4/15/08 1:48 PM Page 1 Cervical Screening A guide for women in New Zealand Taku hauora, taku tinana, taku tūmanako My health, my body, my future Cervical Screening 4/15/08 1:48 PM Page
More informationA Quick Reference Guide to Vaccine Storage & Handling T H E C H AIN
A Quick Reference Guide to Vaccine Storage & Handling MAINTAIN T H E C H AIN MAINTAIN T H E C H AIN A Quick Reference Guide to Vaccine Storage and Handling Copyright Wellington-Dufferin-Guelph Public Health
More informationThe comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting
BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1542 1546 DOI: 10.1111/j.1471-0528.2005.00699.x The comparative diagnostic accuracy of conventional and liquid-based
More informationSECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION
SECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION Introduction Collection of Specimens for Microbiological Examination: Safe Handling of Specimens Packaging & Transportation of Specimens Specimen Rejection
More informationColposcopy. Information for women. Taku hauora, taku tinana, taku tūmanako My health, my body, my future.
Colposcopy Information for women Taku hauora, taku tinana, taku tūmanako My health, my body, my future. www.timetoscreen.nz Kia ora and welcome This information is for women referred to colposcopy (kol-poss-kapee).
More informationNHS cervical screening
NHS cervical screening Cervical screening the facts This leaflet tells you about cervical screening. It aims to help you choose whether or not to take part in the NHS Cervical Screening Programme. What
More informationDeveloped by Marion Wood and Children s Dental Needs Steering Group
Title Document Type Issue no DNA Policy Policy Clinical Governance Support Team Use Issue date 30.05.13 Review date 30.05.15 Distribution Prepared by Dental Staff Marion Wood Developed by Marion Wood and
More informationSCREENING MATTERS - Issue 27
WINTER 2014 EDITION SCREENING MATTERS - Issue 27 What s in this issue? [Front page] Two new videos on what happens at breast & Cervical screening [2] Surveillance screening of women at higher risk Northern
More informationNewborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017
Newborn Bloodspot Screening (NBS) Training for Health Visitors www.newbornbloodspotscreening.wales.nhs.uk December 2017 Aims To enable you to gain a clear understanding of the following: Aim and rationale
More informationConsulted With Post/Committee/Group Date Anita Rao/ Alison Cuthbertson Women s and Children s Clinical
Colposcopy Service Clinical Operational Service Type: Policy Register No: 08026 Status: Public once ratified Developed in response to: NHSCSP20 3 rd edition April 2016 Contributes to CQC Outcome number:
More informationCervical Skills Training Course
Cervical Skills Training Course Competency Workbook Please return to: Christine Paterson Practice Nurse Advisor s Team Room 32 Modular Building Gartnavel Royal Hospital G12 0XH 0141 211 0615 Please return
More informationThe Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series
The Lebanese Society of Obstetrics and Gynecology Women s health promotion series The Pap Smear Test Since the Pap smear test started to be used the number of cases of cervical cancer was greatly reduced.
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationCERVICAL SCREENING UPDATE
CERVICAL SCREENING UPDATE Louise Cadman Research Nurse Consultant and Nurse Colposcopist Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Learning Objectives State the objectives of
More informationPostmenopausal bleeding (PMB) guidelines for women with abnormal vaginal bleeding
Guideline Postmenopausal bleeding (PMB) guidelines for women with abnormal vaginal bleeding 1 Scope For local use. 2 Purpose To provide evidence based care relating to several areas of the service including
More informationCETUXIMAB FOR THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC)
CETUXIMAB FOR THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) 1. BACKGROUND submitted evidence to NICE on the 2 nd cetuximab in the treatment of mcrc. May 2008 for the appraisal of The
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More information6 th EFC Satellite meeting, Saturday 1 st December 2018
6 th EFC Satellite meeting, Saturday 1 st December 2018 Introduction Pekka Nieminen President-elect of the European Federation for Colposcopy, Department of Obstetrics and Gynaecology, Helsinki University
More informationCPC on Cervical Pathology
CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade
More informationSALINA PATHOLOGY LABORATORY
TABLE OF CONTENTS ================================================= REQUISITION... 2 SPECIMEN LABELING... 2 PAP SMEAR SPECIMEN COLLECTION... 3 Patient Preparation... 3 Sample Collection... 3 Placement
More informationThe information contained here may be very important to your practice. Please take a moment to review this document.
August 2016 Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document. TEST BULLETIN ZIKA VIRUS UPDATE! On pages 2 and
More information14. Cancer of the Cervix Uteri
KEY FACTS 14. Cancer of the Cervix Uteri ICD-9 180 On average 78 cases of invasive cervical cancer were registered per year. Half of cases occurred under 49 years of age. 2% of female cancers. Higher than
More informationThe society for lower genital tract disorders since 1964.
The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationHISTOPATHOLOGY DEPARTMENT
HISTOPATHOLOGY DEPARTMENT TITLE: Cytology and andrology user guide INDEX ORGANISATIONAL UNIT AREA OF APPLICATION DOCUMENT TYPE AUTHOR(S) AUTHORISED BY AUTHORISATION DATE DATE PRINTED COPY NUMBER LOCATION
More information!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$
!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology
More informationProgramme Report Irish Cervical Screening Programme. October 2000 to August 2008
Programme Report Irish Cervical Screening Programme October 2000 to August 2008 Members of the Board of the National Cancer Screening Service Dr Sheelah Ryan, Chairperson Dr Gráinne Flannelly Dr Marie
More informationNHS Cervical Screening Programme in Kingston and Richmond ANNUAL REPORT
Kingston Borough Team Richmond and Twickenham Borough Team 1. Introduction NHS Cervical Screening Programme in Kingston and Richmond ANNUAL REPORT 2010-12 All women between the ages of 25 and 64 are eligible
More informationUK National Screening Committee HPV as primary screen for cervical cancer - an evidence review. Consultation comments pro-forma.
UK National Screening Committee HPV as primary screen for cervical cancer - an evidence review Consultation comments pro-forma Name: Sarah May Email address: sarahmay@ibms.org Organisation (if appropriate):
More information